Ultrasonographic Response to Polarized Light Therapy in the Treatment of Atopic Dermatitis
NCT ID: NCT04955951
Last Updated: 2023-08-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
40 participants
OBSERVATIONAL
2021-07-01
2022-01-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Efficacy and Safety of Enhanced External Counter-pulsation on Patients With Atopic Dermatitis and Inflammatory Skin Disease Requiring Wet Wrap Therapy
NCT06448702
Cooling Pillow for Atopic Dermatitis
NCT01132651
Adding Auricular Acupuncture to Xiao-Feng-San Decoction for Treating Atopic Dermatitis
NCT06492902
Skin Pathology Assessment With Optical Technologies
NCT04295824
Characterization of Chronic Hand Eczema
NCT05026554
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
40 male patients who had atopic dermatitis in the chronic stage, they were complaining from itching, inflammation and skin thickness in the arm, wrist, hand and leg will participate in this study.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
polarized light group
group A (20 patients) will receive Polarized light therapy
polarized light
A Bioptron light therapy phototherapeutic device (Bioptron AG, Wollerau, Switzerland) with 5 cm treatment diameter (BIOPTRON MedAll®, 480-3400 nm, polarization level of 95%, power density 40 mW/cm2, energy density 2,4 J/cm2 per minute
topical corticosteroid group
group B (20 patients) will receive topical corticosteroid therapy
Topical corticosteroid ointment
corticosteroid 1 %.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
polarized light
A Bioptron light therapy phototherapeutic device (Bioptron AG, Wollerau, Switzerland) with 5 cm treatment diameter (BIOPTRON MedAll®, 480-3400 nm, polarization level of 95%, power density 40 mW/cm2, energy density 2,4 J/cm2 per minute
Topical corticosteroid ointment
corticosteroid 1 %.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The subjects will be males.
* The duration of disease less than 1 year.
Exclusion Criteria
* The patients who had history of diabetes, circulatory or sensory disorders.
* Patients with acute infection in the area treated.
20 Years
30 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ahram Canadian University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mahmoud H Mohamed, PhD
LECTURER
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ahram Canadian University
Giza, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AhramCUE
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.